tiprankstipranks
Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
US Market
RPHCF
Rohto Pharmaceutical Co
RESEARCH TOOLSreports

Rohto Pharmaceutical Co (RPHCF) Financial Statements

Compare
3 Followers

Rohto Pharmaceutical Co Financial Overview

Rohto Pharmaceutical Co's market cap is currently $3.46B. The company's EPS TTM is $0.29473701; its P/E ratio is 13.97; and it has a dividend yield of 1.70%. Rohto Pharmaceutical Co is scheduled to report earnings on February 12, 2026, and the estimated EPS forecast is $0.24. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 308.63B¥ 270.84B¥ 238.66B¥ 199.65B¥ 181.05B
Gross Profit¥ 169.46B¥ 154.93B¥ 135.13B¥ 114.10B¥ 104.96B
Operating Income¥ 38.47B¥ 40.17B¥ 33.54B¥ 27.86B¥ 21.87B
EBITDA¥ 51.61B¥ 48.85B¥ 41.34B¥ 35.55B¥ 28.61B
Net Income¥ 31.00B¥ 30.94B¥ 26.38B¥ 21.13B¥ 16.74B
Balance Sheet
Cash & Short-Term Investments¥ 77.16B¥ 89.21B¥ 79.95B¥ 72.79B¥ 52.96B
Total Assets¥ 421.88B¥ 346.18B¥ 309.68B¥ 274.88B¥ 226.15B
Total Debt¥ 61.23B¥ 12.81B¥ 12.88B¥ 21.72B¥ 8.49B
Net Debt¥ -15.93B¥ -76.40B¥ -67.07B¥ -51.07B¥ -44.48B
Total Liabilities¥ 150.43B¥ 99.14B¥ 94.60B¥ 90.88B¥ 69.53B
Stockholders' Equity¥ 260.10B¥ 246.33B¥ 209.57B¥ 178.40B¥ 155.91B
Cash Flow
Free Cash Flow¥ 27.84B¥ 26.27B¥ 22.45B¥ 16.98B¥ 11.29B
Operating Cash Flow¥ 36.92B¥ 34.24B¥ 30.92B¥ 27.25B¥ 20.01B
Investing Cash Flow¥ -57.55B¥ -16.32B¥ -13.18B¥ -16.41B¥ -10.24B
Financing Cash Flow¥ 3.70B¥ -13.78B¥ -16.20B¥ 3.47B¥ -2.35B
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History

Income Statement >

Rohto Pharmaceutical Co Debt to Assets

Balance Sheet >

Rohto Pharmaceutical Co Cash Flow

Cash Flow >

Rohto Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >